You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

secondary haemophagocytic lymphohistiocytosis (sHLH)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Trial in Worldwide (ELA026)

Recruiting
  • Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
  • Innsbruck, Austria
  • +9 more
Oct 24, 2022

Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)

Completed
Has Results
  • Macrophage Activation Syndrome
  • +3 more
  • Cincinnati, Ohio
  • +4 more
May 16, 2022

Haemophagocytic Lymphohistiocytosis Trial (Ruxolitinib)

Not yet recruiting
  • Haemophagocytic Lymphohistiocytosis
  • (no location specified)
Feb 28, 2023

Novel Factors Leading to Activated Macrophage Expansion in

Active, not recruiting
  • Covid19
  • SARS-CoV-2 Infection
  • Soton hyperinflammation score
  • HScore
  • Southampton, Hampshire, United Kingdom
    University Hospitals Southampton NHS Foundation Trust
May 25, 2021

COVID-19 Prospective Cohort for Identification of Secondary HLH

Unknown status
  • COVID
    • München, Bavaria, Germany
      Department of nephrology, Klinikum rechts der Isar
    Apr 11, 2020

    Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)

    Recruiting
    • Macrophage Activation Syndrome
    • +6 more
    • Birmingham, Alabama
    • +41 more
    Jan 3, 2023

    COVID-19 Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Pulmonary Fibrosis Trial (cyclosporine)

    Not yet recruiting
    • COVID-19 Acute Respiratory Distress Syndrome
    • +2 more
    • (no location specified)
    Jul 26, 2021

    Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)

    Withdrawn
    • Hemophagocytic Lymphohistiocytosis
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Mar 11, 2022

    Lymphoma-associated Hemophagocytic Lymphohistiocytosis

    Recruiting
    • Lymphoma
    • Hemophagocytic Lymphohistiocytoses
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Jun 1, 2023

      Primary Haemophagocytic Lymphohistiocytosis Trial in Worldwide (NI-0501)

      Completed
      Has Results
      • Primary Haemophagocytic Lymphohistiocytosis
      • NI-0501
      • Aurora, Colorado
      • +19 more
      Apr 23, 2021

      Assessing the Presence of CT-DNA in Lymphoma Associated HLH

      Not yet recruiting
      • Lymphoma
      • Haemophagocytic Lymphohistiocytosis
        • (no location specified)
        Jan 25, 2023

        Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses Trial in Beijing (Carrimycin tablets)

        Not yet recruiting
        • Carbapenem Resistant Bacterial Infection
        • Hemophagocytic Lymphohistiocytoses
        • Carrimycin tablets
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Aug 4, 2023

        Primary Hemophagocytic Lymphohistiocytosis Trial in Worldwide (Emapalumab)

        Active, not recruiting
        • Primary Hemophagocytic Lymphohistiocytosis
        • Phoenix, Arizona
        • +27 more
        Nov 4, 2021

        EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

        Recruiting
        • EBV-associated Hemophagocytic Lymphohistiocytosis
        • EBV Infection
        • EBV-TCR-T cells
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Nov 12, 2023

        PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

        Not yet recruiting
        • PD-1 Antibody
        • +3 more
        • L-DEP and PD-1 antibody
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Mar 8, 2023

        Adults Patients Having Non Severe HLH Trial in Bobigny (Itacitinib)

        Recruiting
        • Adults Patients Having Non Severe HLH
        • Bobigny, France
          Hôpital Avicenne
        Aug 22, 2022

        Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

        Not yet recruiting
        • Refractory
        • +2 more
        • GTP regimen
        • (no location specified)
        Sep 8, 2023

        Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

        Recruiting
        • Hemophagocytic Lymphohistiocytosis
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Sep 15, 2022

        Hemophagocytic Lymphohistiocytoses Trial in Cincinnati

        Recruiting
        • Hemophagocytic Lymphohistiocytoses
          • Cincinnati, Ohio
            Cincinnati Children's Hospital Medical Center
          Oct 25, 2022

          Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

          Recruiting
          • Hemophagocytic Lymphohistiocytosis
          • Phoenix, Arizona
          • +9 more
          Jan 9, 2023

          Hemophagocytic Lymphohistiocytoses, EBV, Metabonomics Trial in Beijing (observational)

          Not yet recruiting
          • Hemophagocytic Lymphohistiocytoses
          • +2 more
          • observational
          • Beijing, Beijing, China
            Beijing Friendship Hospital, Capital Medical University
          Dec 22, 2022

          Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

          Recruiting
          • Secondary Hemophagocytic Lymphohistiocytosis
          • Chronic Active Epstein-Barr Virus Infection
          • No intervention
          • Beijing, Beijing, China
            Beijing Friendship Hospital, Capital Medical University
          May 2, 2023

          IFN? and Inflammatory Mediators in Hemophagocytic

          Completed
          • Hemophagocytic Lymphohistiocytoses
          • Blood Draws Data Collection
          • Boston, Massachusetts
            Brigham and Women's Hospital
          Sep 14, 2023

          Hemophagocytic Lymphohistiocytosis Trial in Beijing (L-DEP and PD-1 antibody)

          Not yet recruiting
          • Hemophagocytic Lymphohistiocytosis
          • L-DEP and PD-1 antibody
          • Beijing, China
            Beijing Friendship Hospital, Capital Medical University
          Apr 19, 2022

          Prospective Validation of the OHI Index

          Recruiting
          • HLH
          • +4 more
            • Kfar Saba, Israel
            • +1 more
            May 21, 2023